PRLB — Proto Labs Income Statement
0.000.00%
- $836.01m
- $733.52m
- $500.89m
- 96
- 59
- 92
- 96
Annual income statement for Proto Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 434 | 488 | 488 | 504 | 501 |
Cost of Revenue | |||||
Gross Profit | 218 | 223 | 215 | 222 | 223 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 375 | 448 | 586 | 476 | 481 |
Operating Profit | 59.8 | 40.3 | -98 | 28.2 | 19.9 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 62.9 | 40.2 | -97.9 | 28 | 24.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 50.9 | 33.4 | -103 | 17.2 | 16.6 |
Net Income Before Extraordinary Items | |||||
Net Income | 50.9 | 33.4 | -103 | 17.2 | 16.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 50.9 | 33.4 | -103 | 17.2 | 16.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.89 | 1.21 | -0.812 | 0.662 | 0.807 |